Becton Dickinson and Co
BDX180.180USD
-26.910-12.99%
交易中 （美東）報價延遲15分鐘
51.74B總市值
29.96本益比TTM
關於 Becton Dickinson and Co 公司
碧迪醫療是一家全球醫療技術公司。該公司從事醫療機構、醫生、生命科學研究人員、臨牀實驗室等使用的各種醫療用品、設備、實驗室設備和診斷產品的開發、製造和銷售。其 BD 醫療部門生產一系列醫療技術和設備，用於幫助改善各種環境中的醫療服務。BD 醫療部門由多個業務部門組成，包括藥物輸送解決方案、藥物管理解決方案、高級監控和製藥系統。其 BD 生命科學部門提供用於收集和運輸診斷樣本的產品，以及用於檢測各種傳染病、醫療相關感染和癌症的儀器和試劑系統。其 BD 介入部門提供血管、泌尿科、腫瘤科和外科專業產品。
公司簡介
公司代碼BDX
公司名稱Becton Dickinson and Co
上市日期Sep 25, 1963
成立日期1906
CEOMr. Thomas E. Polen
員工數量74000
證券類型Ordinary Share
年結日Sep 25
公司地址One Becton Drive
城市FRANKLIN LAKES
上市交易所NYSE Consolidated
國家United States of America
郵編07417-1880
電話12018476800
網址https://www.bd.com/
公司代碼BDX
上市日期Sep 25, 1963
成立日期1906
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
9.19K
+38.45%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.14K
+11.33%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+39.80%
Dr. Carrie L. Byington, M.D.
Dr. Carrie L. Byington, M.D.
Independent Director
Independent Director
5.25K
+21.54%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Medication Delivery Solutions
1.12B
21.75%
Medication Management Solutions
801.00M
15.50%
Integrated Diagnostic Solutions
474.00M
9.17%
Peripheral Intervention
473.00M
9.15%
Specimen Management
462.00M
8.94%
Other
1.83B
35.49%
地區USD
名稱
營收
佔比
United States
3.08B
59.58%
International
2.09B
40.42%
業務
地區
業務USD
名稱
營收
佔比
Medication Delivery Solutions
1.12B
21.75%
Medication Management Solutions
801.00M
15.50%
Integrated Diagnostic Solutions
474.00M
9.17%
Peripheral Intervention
473.00M
9.15%
Specimen Management
462.00M
8.94%
Other
1.83B
35.49%
股東統計
更新時間: 4月26日 週六
更新時間: 4月26日 週六
持股股東
股東類型
持股股東
股東統計
佔比
The Vanguard Group, Inc.
9.27%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.91%
T. Rowe Price Investment Management, Inc.
4.22%
T. Rowe Price Associates, Inc.
4.15%
Other
72.29%
持股股東
股東統計
佔比
The Vanguard Group, Inc.
9.27%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.91%
T. Rowe Price Investment Management, Inc.
4.22%
T. Rowe Price Associates, Inc.
4.15%
Other
72.29%
股東類型
股東統計
佔比
Investment Advisor
41.45%
Investment Advisor/Hedge Fund
40.99%
Pension Fund
2.83%
Hedge Fund
2.51%
Research Firm
2.37%
Bank and Trust
1.64%
Sovereign Wealth Fund
1.23%
Individual Investor
0.57%
Insurance Company
0.28%
Other
6.12%
機構持股
更新時間: 1月19日 週日
更新時間: 1月19日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
2842
271.04M
94.39%
-4.33M
2024Q4
2874
271.53M
94.56%
-4.62M
2024Q3
2787
266.29M
92.14%
-3.20M
2024Q2
2782
261.01M
90.31%
-2.68M
2024Q1
2797
255.99M
88.58%
-10.13M
2023Q4
2783
259.38M
89.78%
-7.79M
2023Q3
2768
264.64M
91.23%
-591.87K
2023Q2
2787
263.29M
90.78%
-570.64K
2023Q1
2795
257.22M
90.56%
-8.75M
2022Q4
2831
255.72M
90.07%
-14.76M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
26.61M
9.27%
+188.34K
+0.71%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
14.81M
5.16%
+196.28K
+1.34%
Dec 31, 2024
State Street Global Advisors (US)
14.09M
4.91%
+134.36K
+0.96%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
12.13M
4.22%
+3.22M
+36.14%
Dec 31, 2024
T. Rowe Price Associates, Inc.
11.93M
4.15%
-1.16M
-8.84%
Dec 31, 2024
Geode Capital Management, L.L.C.
6.35M
2.21%
+66.02K
+1.05%
Dec 31, 2024
Generation Investment Management LLP
5.82M
2.03%
-139.25K
-2.34%
Dec 31, 2024
Morgan Stanley Investment Management Ltd. (UK)
5.70M
1.98%
-310.28K
-5.16%
Dec 31, 2024
MFS Investment Management
5.45M
1.9%
+708.73K
+14.93%
Dec 31, 2024
First Eagle Investment Management, L.L.C.
4.43M
1.54%
+1.06M
+31.36%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
iShares U.S. Medical Devices ETF
4.18%
Natixis Vaughan Nelson Select ETF
4.12%
ClearBridge Dividend Strategy ESG ETF
3.3%
T Rowe Price Capital Appreciation Equity ETF
2.93%
First Eagle Global Equity ETF
2.82%
American Century Focused Large Cap Value ETF
2.61%
Touchstone US Large Cap Focused ETF
1.86%
ProShares MSCI Transformational Changes ETF
1.84%
T Rowe Price Equity Income ETF
1.76%
Running Oak Efficient Growth ETF
1.73%
查看更多
iShares U.S. Medical Devices ETF
佔比4.18%
Natixis Vaughan Nelson Select ETF
佔比4.12%
ClearBridge Dividend Strategy ESG ETF
佔比3.3%
T Rowe Price Capital Appreciation Equity ETF
佔比2.93%
First Eagle Global Equity ETF
佔比2.82%
American Century Focused Large Cap Value ETF
佔比2.61%
Touchstone US Large Cap Focused ETF
佔比1.86%
ProShares MSCI Transformational Changes ETF
佔比1.84%
T Rowe Price Equity Income ETF
佔比1.76%
Running Oak Efficient Growth ETF
佔比1.73%
分紅派息
近5年累計派現
5.34B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Apr 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 30, 2023
Jun 08, 2023
Jan 24, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 31, 2023
Mar 09, 2023
Nov 10, 2022
BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022
Dec 09, 2022
Dec 30, 2022
Dec 08, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據